| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Natural Killer T-Cells | 16 | 2020 | 322 | 2.880 |
Why?
|
| Mycobacterium | 25 | 2019 | 251 | 1.860 |
Why?
|
| Leprosy | 11 | 2014 | 126 | 1.350 |
Why?
|
| Antigens, Bacterial | 18 | 2014 | 1155 | 1.260 |
Why?
|
| Lymphocyte Activation | 10 | 2019 | 5486 | 1.100 |
Why?
|
| Mycobacterium leprae | 13 | 2014 | 95 | 1.030 |
Why?
|
| Hypersensitivity | 3 | 2024 | 1171 | 1.000 |
Why?
|
| Lymphoid Enhancer-Binding Factor 1 | 1 | 2024 | 84 | 0.890 |
Why?
|
| T Cell Transcription Factor 1 | 1 | 2024 | 72 | 0.890 |
Why?
|
| Skin Tests | 3 | 2014 | 637 | 0.870 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 1 | 2024 | 174 | 0.850 |
Why?
|
| Cross Infection | 7 | 2015 | 1422 | 0.830 |
Why?
|
| Multipotent Stem Cells | 1 | 2024 | 200 | 0.820 |
Why?
|
| Lipopolysaccharides | 22 | 2018 | 2206 | 0.820 |
Why?
|
| Mycobacterium tuberculosis | 29 | 2012 | 1914 | 0.810 |
Why?
|
| Glycolipids | 11 | 2020 | 206 | 0.800 |
Why?
|
| Galactans | 10 | 2002 | 31 | 0.790 |
Why?
|
| Antigens, CD1d | 4 | 2020 | 228 | 0.710 |
Why?
|
| Hypersensitivity, Immediate | 1 | 2022 | 347 | 0.670 |
Why?
|
| Personnel, Hospital | 1 | 2021 | 285 | 0.670 |
Why?
|
| Food Hypersensitivity | 3 | 2022 | 729 | 0.660 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 4 | 2017 | 800 | 0.660 |
Why?
|
| Galactosylceramides | 2 | 2017 | 92 | 0.650 |
Why?
|
| Th2 Cells | 2 | 2024 | 1060 | 0.640 |
Why?
|
| Mycolic Acids | 12 | 2004 | 54 | 0.610 |
Why?
|
| Caffeine | 1 | 2022 | 700 | 0.600 |
Why?
|
| Mycobacterium smegmatis | 10 | 2006 | 126 | 0.580 |
Why?
|
| Antigen Presentation | 6 | 2016 | 1251 | 0.520 |
Why?
|
| Glucosylceramides | 1 | 2014 | 28 | 0.480 |
Why?
|
| Receptors, Antigen, T-Cell | 7 | 2016 | 2547 | 0.470 |
Why?
|
| Neglected Diseases | 1 | 2014 | 66 | 0.440 |
Why?
|
| Cell Wall | 16 | 2006 | 425 | 0.430 |
Why?
|
| Trehalose | 6 | 2019 | 88 | 0.420 |
Why?
|
| Drug Hypersensitivity | 4 | 2020 | 917 | 0.410 |
Why?
|
| Bacterial Infections | 2 | 2011 | 1390 | 0.400 |
Why?
|
| Phenylthiourea | 2 | 2003 | 10 | 0.400 |
Why?
|
| Antitubercular Agents | 8 | 2003 | 1375 | 0.390 |
Why?
|
| T-Lymphocyte Subsets | 7 | 2019 | 1802 | 0.390 |
Why?
|
| Glycosphingolipids | 1 | 2011 | 73 | 0.380 |
Why?
|
| Vaccination | 3 | 2023 | 3384 | 0.370 |
Why?
|
| Lymphocytes | 1 | 2019 | 2612 | 0.370 |
Why?
|
| Desensitization, Immunologic | 3 | 2020 | 556 | 0.350 |
Why?
|
| Chromatography, Thin Layer | 12 | 2014 | 213 | 0.340 |
Why?
|
| Infection Control | 4 | 2011 | 981 | 0.340 |
Why?
|
| Equipment Contamination | 1 | 2011 | 182 | 0.330 |
Why?
|
| Sphingolipids | 2 | 2022 | 174 | 0.320 |
Why?
|
| Enterococcus | 3 | 1999 | 159 | 0.320 |
Why?
|
| Bacteremia | 3 | 2011 | 979 | 0.310 |
Why?
|
| Philadelphia | 5 | 2022 | 266 | 0.310 |
Why?
|
| Spectrometry, Mass, Fast Atom Bombardment | 10 | 2002 | 33 | 0.300 |
Why?
|
| Catheters | 1 | 2011 | 427 | 0.290 |
Why?
|
| Catheter-Related Infections | 1 | 2011 | 273 | 0.290 |
Why?
|
| Carbohydrate Sequence | 13 | 2007 | 411 | 0.290 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2021 | 3205 | 0.290 |
Why?
|
| Gram-Positive Bacterial Infections | 3 | 1999 | 343 | 0.290 |
Why?
|
| Cell Proliferation | 7 | 2024 | 10445 | 0.290 |
Why?
|
| Autoantigens | 1 | 2011 | 891 | 0.280 |
Why?
|
| Transcription, Genetic | 6 | 2015 | 7594 | 0.280 |
Why?
|
| Vancomycin | 3 | 1999 | 503 | 0.280 |
Why?
|
| Immunologic Memory | 2 | 2013 | 1359 | 0.280 |
Why?
|
| Immune Tolerance | 3 | 2005 | 2303 | 0.270 |
Why?
|
| Immunity, Innate | 3 | 2019 | 3065 | 0.260 |
Why?
|
| Neuraminidase | 1 | 2005 | 196 | 0.250 |
Why?
|
| Molecular Sequence Data | 31 | 2007 | 17635 | 0.250 |
Why?
|
| Carbohydrate Conformation | 10 | 1997 | 206 | 0.240 |
Why?
|
| Comparative Effectiveness Research | 1 | 2010 | 709 | 0.240 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 7 | 2018 | 353 | 0.240 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2009 | 587 | 0.240 |
Why?
|
| Patient Care | 1 | 2010 | 622 | 0.240 |
Why?
|
| Safety Management | 1 | 2010 | 760 | 0.240 |
Why?
|
| Cell Degranulation | 2 | 2022 | 277 | 0.230 |
Why?
|
| Phosphatidylinositols | 4 | 2002 | 282 | 0.230 |
Why?
|
| Vaccines | 2 | 2023 | 844 | 0.230 |
Why?
|
| Polysaccharides, Bacterial | 3 | 1997 | 578 | 0.230 |
Why?
|
| Ethambutol | 4 | 1997 | 59 | 0.230 |
Why?
|
| Health Facilities | 1 | 2009 | 580 | 0.230 |
Why?
|
| Mice | 33 | 2024 | 81525 | 0.230 |
Why?
|
| CD8-Positive T-Lymphocytes | 4 | 2019 | 4580 | 0.230 |
Why?
|
| Antigens, CD1 | 5 | 2012 | 439 | 0.220 |
Why?
|
| Cyclins | 1 | 2006 | 594 | 0.220 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2006 | 484 | 0.220 |
Why?
|
| Animals | 44 | 2024 | 168459 | 0.220 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2006 | 502 | 0.220 |
Why?
|
| Fatty Acid Desaturases | 1 | 2003 | 100 | 0.220 |
Why?
|
| Clonal Anergy | 2 | 2003 | 170 | 0.210 |
Why?
|
| T-Lymphocytes | 9 | 2013 | 10194 | 0.210 |
Why?
|
| Hospitals | 2 | 2021 | 3882 | 0.210 |
Why?
|
| Milk | 2 | 2017 | 443 | 0.210 |
Why?
|
| CD4-Positive T-Lymphocytes | 7 | 2014 | 4369 | 0.210 |
Why?
|
| Linoleic Acid | 1 | 2024 | 158 | 0.210 |
Why?
|
| Drug Resistance, Microbial | 6 | 1999 | 825 | 0.210 |
Why?
|
| Bacillaceae Infections | 1 | 2011 | 8 | 0.200 |
Why?
|
| Tuberculosis | 8 | 2012 | 2017 | 0.200 |
Why?
|
| Antibodies, Monoclonal | 5 | 2018 | 9177 | 0.200 |
Why?
|
| Receptors, Neuropeptide | 1 | 2022 | 106 | 0.200 |
Why?
|
| Bacillus cereus | 1 | 2011 | 36 | 0.200 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2023 | 368 | 0.190 |
Why?
|
| Cell Differentiation | 6 | 2024 | 11528 | 0.190 |
Why?
|
| Intramolecular Transferases | 1 | 2000 | 14 | 0.190 |
Why?
|
| Humans | 79 | 2024 | 761504 | 0.180 |
Why?
|
| Polyisoprenyl Phosphates | 1 | 2000 | 38 | 0.180 |
Why?
|
| Receptors, Death Domain | 1 | 2020 | 31 | 0.180 |
Why?
|
| Bacterial Proteins | 12 | 2006 | 3847 | 0.170 |
Why?
|
| Allergens | 3 | 2022 | 1432 | 0.170 |
Why?
|
| Anti-Bacterial Agents | 7 | 2011 | 7407 | 0.170 |
Why?
|
| Tuberculosis, Pulmonary | 3 | 2018 | 832 | 0.170 |
Why?
|
| Glycopeptides | 3 | 2000 | 220 | 0.160 |
Why?
|
| Thiourea | 1 | 1999 | 68 | 0.160 |
Why?
|
| Chloramphenicol | 1 | 1998 | 67 | 0.160 |
Why?
|
| Blood | 1 | 2011 | 596 | 0.160 |
Why?
|
| Isoniazid | 2 | 1999 | 283 | 0.160 |
Why?
|
| Macrophages, Alveolar | 2 | 2019 | 412 | 0.160 |
Why?
|
| Pentosyltransferases | 5 | 1998 | 62 | 0.160 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2019 | 150 | 0.160 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 3 | 2017 | 266 | 0.150 |
Why?
|
| Leukotrienes | 1 | 2019 | 231 | 0.150 |
Why?
|
| GTP-Binding Proteins | 1 | 2022 | 951 | 0.150 |
Why?
|
| Milk, Human | 1 | 2022 | 486 | 0.150 |
Why?
|
| Kruppel-Like Transcription Factors | 3 | 2017 | 504 | 0.150 |
Why?
|
| Interferon-gamma | 9 | 2012 | 3162 | 0.150 |
Why?
|
| Mycobacteriophages | 2 | 1996 | 19 | 0.150 |
Why?
|
| Biological Assay | 2 | 2019 | 626 | 0.150 |
Why?
|
| Virulence Factors | 1 | 2011 | 513 | 0.150 |
Why?
|
| Medicare | 2 | 2017 | 6770 | 0.150 |
Why?
|
| Mannose | 3 | 2012 | 121 | 0.150 |
Why?
|
| Sequence Homology, Amino Acid | 10 | 2006 | 2748 | 0.150 |
Why?
|
| Cells, Cultured | 9 | 2024 | 18965 | 0.150 |
Why?
|
| Basophils | 1 | 2020 | 407 | 0.150 |
Why?
|
| Salmonella typhi | 1 | 2019 | 198 | 0.140 |
Why?
|
| Skin Diseases, Bacterial | 2 | 1995 | 68 | 0.140 |
Why?
|
| Mannosyltransferases | 3 | 2002 | 23 | 0.140 |
Why?
|
| Lymphedema | 1 | 2023 | 525 | 0.140 |
Why?
|
| Biological Specimen Banks | 1 | 2022 | 783 | 0.140 |
Why?
|
| T-Lymphocytes, Regulatory | 3 | 2024 | 3080 | 0.140 |
Why?
|
| Gene Expression Regulation | 6 | 2014 | 11903 | 0.140 |
Why?
|
| Cloning, Molecular | 8 | 2003 | 4174 | 0.140 |
Why?
|
| Promoter Regions, Genetic | 4 | 2006 | 5789 | 0.130 |
Why?
|
| Hospitalization | 2 | 2021 | 10723 | 0.130 |
Why?
|
| Cytotoxicity, Immunologic | 3 | 2017 | 1351 | 0.130 |
Why?
|
| Oligosaccharides | 3 | 1996 | 406 | 0.130 |
Why?
|
| Macrophages | 7 | 2024 | 5769 | 0.130 |
Why?
|
| Cluster Analysis | 4 | 2014 | 2707 | 0.130 |
Why?
|
| Phospholipids | 2 | 2019 | 786 | 0.130 |
Why?
|
| Anti-Infective Agents, Urinary | 1 | 1995 | 28 | 0.130 |
Why?
|
| Sugar Alcohols | 1 | 1995 | 18 | 0.130 |
Why?
|
| Amino Acid Sequence | 16 | 2006 | 13446 | 0.130 |
Why?
|
| Glycolates | 1 | 1995 | 40 | 0.120 |
Why?
|
| Mast Cells | 1 | 2022 | 1392 | 0.120 |
Why?
|
| Quality of Health Care | 1 | 2010 | 4330 | 0.120 |
Why?
|
| Amoeba | 1 | 2014 | 20 | 0.120 |
Why?
|
| Cytokines | 3 | 2024 | 7396 | 0.120 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2022 | 1250 | 0.120 |
Why?
|
| Magnetic Resonance Spectroscopy | 10 | 1997 | 3769 | 0.120 |
Why?
|
| Armadillos | 1 | 2014 | 7 | 0.120 |
Why?
|
| Cattle Diseases | 1 | 1994 | 51 | 0.120 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2018 | 3810 | 0.120 |
Why?
|
| Leukocytes, Mononuclear | 3 | 2019 | 1844 | 0.120 |
Why?
|
| Cell Membrane | 6 | 2019 | 3688 | 0.120 |
Why?
|
| Dendritic Cells | 6 | 2020 | 2747 | 0.120 |
Why?
|
| B-Lymphocytes | 2 | 2017 | 4758 | 0.120 |
Why?
|
| Cell Line | 9 | 2014 | 15601 | 0.120 |
Why?
|
| Interleukin-1beta | 1 | 2020 | 999 | 0.120 |
Why?
|
| Signal Transduction | 7 | 2020 | 23445 | 0.110 |
Why?
|
| Leprosy, Lepromatous | 2 | 2011 | 23 | 0.110 |
Why?
|
| Immunophenotyping | 1 | 2019 | 1870 | 0.110 |
Why?
|
| Drug Stability | 1 | 2014 | 291 | 0.110 |
Why?
|
| Hospital Administration | 2 | 2010 | 353 | 0.110 |
Why?
|
| Lectins, C-Type | 4 | 2019 | 585 | 0.110 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 1995 | 242 | 0.110 |
Why?
|
| Glucosylceramidase | 1 | 2014 | 127 | 0.110 |
Why?
|
| Flow Cytometry | 4 | 2014 | 5869 | 0.110 |
Why?
|
| Guinea Pigs | 2 | 2014 | 1310 | 0.110 |
Why?
|
| Fatty Acids | 6 | 2004 | 1808 | 0.110 |
Why?
|
| Globosides | 1 | 2013 | 11 | 0.110 |
Why?
|
| Health Planning | 1 | 1995 | 230 | 0.110 |
Why?
|
| Trihexosylceramides | 1 | 2013 | 31 | 0.110 |
Why?
|
| Molecular Structure | 6 | 2000 | 1880 | 0.110 |
Why?
|
| Metabolomics | 1 | 2022 | 1659 | 0.110 |
Why?
|
| Mycobacterium avium | 2 | 2007 | 29 | 0.110 |
Why?
|
| Bacteriological Techniques | 1 | 2014 | 275 | 0.110 |
Why?
|
| Mass Spectrometry | 5 | 2014 | 2192 | 0.110 |
Why?
|
| Female | 27 | 2023 | 392644 | 0.100 |
Why?
|
| Social Class | 1 | 2021 | 2004 | 0.100 |
Why?
|
| Receptor, erbB-2 | 2 | 2000 | 2557 | 0.100 |
Why?
|
| Pharmaceutical Preparations | 1 | 2020 | 1089 | 0.100 |
Why?
|
| Drugs, Investigational | 1 | 2014 | 212 | 0.100 |
Why?
|
| Pneumonia | 1 | 2024 | 2143 | 0.100 |
Why?
|
| Nurses | 1 | 2021 | 2478 | 0.100 |
Why?
|
| Cattle | 2 | 2014 | 3849 | 0.100 |
Why?
|
| Histocompatibility Antigens Class II | 2 | 2007 | 1435 | 0.100 |
Why?
|
| Mice, Inbred Strains | 1 | 2014 | 1762 | 0.100 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2017 | 746 | 0.100 |
Why?
|
| Virulence Factors, Bordetella | 1 | 1991 | 154 | 0.100 |
Why?
|
| Pertussis Toxin | 1 | 1991 | 176 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 10 | 2020 | 22169 | 0.090 |
Why?
|
| Lymphoma, T-Cell | 1 | 2014 | 304 | 0.090 |
Why?
|
| Male | 26 | 2023 | 360804 | 0.090 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 3 | 2013 | 899 | 0.090 |
Why?
|
| Antigens, CD | 4 | 2013 | 4003 | 0.090 |
Why?
|
| Ethionamide | 2 | 2000 | 11 | 0.090 |
Why?
|
| Serum | 1 | 2011 | 209 | 0.090 |
Why?
|
| Tissue Distribution | 1 | 2014 | 2265 | 0.090 |
Why?
|
| Antibiotic Prophylaxis | 1 | 1995 | 636 | 0.090 |
Why?
|
| Lymphoid Tissue | 1 | 2011 | 445 | 0.090 |
Why?
|
| Information Management | 1 | 2010 | 100 | 0.090 |
Why?
|
| Nerve Tissue Proteins | 1 | 2022 | 4414 | 0.080 |
Why?
|
| Borderline Personality Disorder | 1 | 2017 | 768 | 0.080 |
Why?
|
| Emergency Medical Services | 1 | 2021 | 1923 | 0.080 |
Why?
|
| Subcellular Fractions | 2 | 2002 | 532 | 0.080 |
Why?
|
| Antigen-Antibody Complex | 1 | 1991 | 510 | 0.080 |
Why?
|
| Fatty Acids, Unsaturated | 2 | 2011 | 540 | 0.080 |
Why?
|
| Education, Medical, Graduate | 2 | 2015 | 2373 | 0.080 |
Why?
|
| Transferases (Other Substituted Phosphate Groups) | 2 | 2019 | 36 | 0.080 |
Why?
|
| Mice, Knockout | 5 | 2014 | 14414 | 0.080 |
Why?
|
| Galactosyltransferases | 2 | 2001 | 276 | 0.080 |
Why?
|
| Quantitative Trait Loci | 2 | 2014 | 2116 | 0.080 |
Why?
|
| Mannans | 2 | 2007 | 58 | 0.080 |
Why?
|
| Interleukin-2 | 4 | 2014 | 1889 | 0.080 |
Why?
|
| Patient Isolation | 1 | 2009 | 100 | 0.080 |
Why?
|
| Hospital Costs | 1 | 1995 | 947 | 0.080 |
Why?
|
| Pneumonia, Aspiration | 1 | 2009 | 146 | 0.080 |
Why?
|
| Program Development | 1 | 2015 | 1297 | 0.080 |
Why?
|
| Mice, Inbred BALB C | 2 | 2011 | 6216 | 0.080 |
Why?
|
| Immunity | 1 | 2014 | 996 | 0.080 |
Why?
|
| Antigens, Differentiation | 1 | 1991 | 910 | 0.080 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 1995 | 1784 | 0.080 |
Why?
|
| Mycobacterium bovis | 3 | 2003 | 147 | 0.080 |
Why?
|
| Species Specificity | 3 | 2013 | 2414 | 0.080 |
Why?
|
| Antibody Specificity | 2 | 2018 | 1060 | 0.080 |
Why?
|
| Cell-Free System | 3 | 2003 | 340 | 0.080 |
Why?
|
| Chemokine CXCL12 | 1 | 2010 | 454 | 0.070 |
Why?
|
| Thymus Gland | 1 | 2012 | 1243 | 0.070 |
Why?
|
| Technology Assessment, Biomedical | 1 | 2010 | 307 | 0.070 |
Why?
|
| Immune System | 1 | 2013 | 796 | 0.070 |
Why?
|
| Receptors, Fc | 1 | 1991 | 535 | 0.070 |
Why?
|
| DNA, Bacterial | 5 | 2009 | 1479 | 0.070 |
Why?
|
| Acyltransferases | 2 | 2001 | 305 | 0.070 |
Why?
|
| Electronic Health Records | 2 | 2022 | 4811 | 0.070 |
Why?
|
| Immunoprecipitation | 2 | 2010 | 878 | 0.070 |
Why?
|
| Lectins | 2 | 2006 | 491 | 0.070 |
Why?
|
| Carbon Radioisotopes | 3 | 1998 | 561 | 0.070 |
Why?
|
| Blotting, Western | 2 | 2006 | 5035 | 0.070 |
Why?
|
| Pneumonia, Ventilator-Associated | 1 | 2011 | 279 | 0.070 |
Why?
|
| Adult | 19 | 2021 | 221177 | 0.070 |
Why?
|
| Models, Chemical | 3 | 2007 | 611 | 0.070 |
Why?
|
| Chemotaxis | 1 | 2010 | 598 | 0.070 |
Why?
|
| Middle Aged | 17 | 2021 | 220895 | 0.070 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2009 | 694 | 0.070 |
Why?
|
| Peptidoglycan | 3 | 2007 | 249 | 0.070 |
Why?
|
| Adhesins, Bacterial | 1 | 2006 | 118 | 0.070 |
Why?
|
| Genetic Variation | 3 | 2014 | 6567 | 0.070 |
Why?
|
| Polysaccharides | 3 | 1997 | 1014 | 0.070 |
Why?
|
| Immunologic Deficiency Syndromes | 2 | 2007 | 547 | 0.070 |
Why?
|
| Interleukin-4 | 2 | 2024 | 1149 | 0.070 |
Why?
|
| Cyclin D2 | 1 | 2006 | 98 | 0.070 |
Why?
|
| Child, Preschool | 5 | 2022 | 42230 | 0.070 |
Why?
|
| Celiac Disease | 1 | 2014 | 821 | 0.070 |
Why?
|
| Tuberculin Test | 1 | 2006 | 206 | 0.060 |
Why?
|
| Chromatography, Gas | 2 | 2003 | 151 | 0.060 |
Why?
|
| Pennsylvania | 3 | 2015 | 613 | 0.060 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2006 | 293 | 0.060 |
Why?
|
| Safety | 1 | 2010 | 1150 | 0.060 |
Why?
|
| Immunologic Tests | 1 | 2006 | 104 | 0.060 |
Why?
|
| Proteolipids | 1 | 2005 | 113 | 0.060 |
Why?
|
| Advisory Committees | 1 | 2010 | 787 | 0.060 |
Why?
|
| Acylation | 3 | 1994 | 96 | 0.060 |
Why?
|
| Cell Communication | 1 | 2013 | 1657 | 0.060 |
Why?
|
| Infant | 3 | 2022 | 36192 | 0.060 |
Why?
|
| Bacterial Adhesion | 1 | 2006 | 306 | 0.060 |
Why?
|
| Bacterial Typing Techniques | 1 | 2006 | 263 | 0.060 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2007 | 347 | 0.060 |
Why?
|
| Hospitals, University | 2 | 1999 | 563 | 0.060 |
Why?
|
| Guanosine Diphosphate Mannose | 3 | 2002 | 4 | 0.060 |
Why?
|
| Costs and Cost Analysis | 1 | 2011 | 1668 | 0.060 |
Why?
|
| Mice, Inbred CBA | 1 | 2005 | 436 | 0.060 |
Why?
|
| Microbial Sensitivity Tests | 4 | 2011 | 1937 | 0.060 |
Why?
|
| Phosphotyrosine | 1 | 2005 | 456 | 0.060 |
Why?
|
| Disease Notification | 1 | 2005 | 95 | 0.060 |
Why?
|
| Leukocytes | 1 | 2013 | 2026 | 0.060 |
Why?
|
| Mannosides | 2 | 2001 | 7 | 0.060 |
Why?
|
| Cell Transformation, Viral | 1 | 2006 | 526 | 0.060 |
Why?
|
| Carbazoles | 1 | 2006 | 220 | 0.060 |
Why?
|
| Urinary Tract Infections | 1 | 2011 | 802 | 0.060 |
Why?
|
| Metabolome | 1 | 2011 | 989 | 0.060 |
Why?
|
| Isoquinolines | 1 | 2006 | 352 | 0.060 |
Why?
|
| Genes, Bacterial | 2 | 1999 | 1073 | 0.060 |
Why?
|
| Professional Competence | 1 | 2007 | 431 | 0.060 |
Why?
|
| Computational Biology | 2 | 2014 | 3518 | 0.060 |
Why?
|
| Valerates | 1 | 2004 | 20 | 0.060 |
Why?
|
| Mandatory Reporting | 1 | 2005 | 123 | 0.060 |
Why?
|
| Mice, Transgenic | 3 | 2009 | 9539 | 0.060 |
Why?
|
| Mannose-Binding Lectins | 1 | 2004 | 96 | 0.060 |
Why?
|
| Actins | 1 | 1991 | 2050 | 0.060 |
Why?
|
| Stearic Acids | 1 | 2003 | 56 | 0.060 |
Why?
|
| Immunoglobulin E | 2 | 2020 | 1502 | 0.060 |
Why?
|
| Oligopeptides | 2 | 2000 | 1187 | 0.050 |
Why?
|
| Physicians | 1 | 2021 | 4591 | 0.050 |
Why?
|
| Autoimmunity | 1 | 2011 | 1356 | 0.050 |
Why?
|
| Health Care Surveys | 1 | 2011 | 2426 | 0.050 |
Why?
|
| Chromatography, Gel | 3 | 2002 | 645 | 0.050 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2006 | 330 | 0.050 |
Why?
|
| Oleic Acid | 1 | 2003 | 92 | 0.050 |
Why?
|
| Enzyme Inhibitors | 3 | 2006 | 3712 | 0.050 |
Why?
|
| Langerhans Cells | 1 | 2004 | 170 | 0.050 |
Why?
|
| Stearoyl-CoA Desaturase | 1 | 2003 | 85 | 0.050 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2007 | 386 | 0.050 |
Why?
|
| Attitude of Health Personnel | 1 | 2017 | 3889 | 0.050 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2003 | 1741 | 0.050 |
Why?
|
| Bioterrorism | 1 | 2004 | 144 | 0.050 |
Why?
|
| Leadership | 2 | 2015 | 1385 | 0.050 |
Why?
|
| Gene Expression Profiling | 3 | 2014 | 9420 | 0.050 |
Why?
|
| Phosphorylation | 3 | 2013 | 8320 | 0.050 |
Why?
|
| Adipose Tissue | 1 | 2014 | 3312 | 0.050 |
Why?
|
| Drug Implants | 1 | 2003 | 230 | 0.050 |
Why?
|
| Neutrophils | 2 | 2014 | 3767 | 0.050 |
Why?
|
| Inflammation | 2 | 2019 | 10773 | 0.050 |
Why?
|
| Cyclopropanes | 1 | 2004 | 432 | 0.050 |
Why?
|
| Polymers | 4 | 2002 | 1617 | 0.050 |
Why?
|
| Retrospective Studies | 5 | 2022 | 80636 | 0.050 |
Why?
|
| Cross Reactions | 3 | 1993 | 817 | 0.050 |
Why?
|
| Autoimmune Diseases | 1 | 2014 | 2244 | 0.050 |
Why?
|
| Epitopes, T-Lymphocyte | 2 | 2005 | 828 | 0.050 |
Why?
|
| Kinetics | 3 | 2001 | 6374 | 0.050 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 1 | 2011 | 142 | 0.050 |
Why?
|
| Glycosyltransferases | 1 | 2002 | 117 | 0.050 |
Why?
|
| Epitopes, B-Lymphocyte | 1 | 2002 | 83 | 0.050 |
Why?
|
| Surgical Wound Infection | 1 | 2011 | 1527 | 0.050 |
Why?
|
| Molecular Typing | 1 | 2011 | 116 | 0.050 |
Why?
|
| Regression Analysis | 1 | 2011 | 6343 | 0.050 |
Why?
|
| Phenols | 2 | 1998 | 517 | 0.050 |
Why?
|
| Acetyltransferases | 1 | 2002 | 231 | 0.050 |
Why?
|
| Nitric Oxide Synthase | 2 | 2001 | 908 | 0.050 |
Why?
|
| Schools, Medical | 1 | 2007 | 879 | 0.050 |
Why?
|
| PPAR gamma | 1 | 2023 | 484 | 0.050 |
Why?
|
| Substrate Specificity | 3 | 2001 | 1791 | 0.050 |
Why?
|
| Sensitivity and Specificity | 3 | 2014 | 14666 | 0.050 |
Why?
|
| Pregnancy | 1 | 2022 | 29874 | 0.050 |
Why?
|
| Sequence Analysis, Protein | 1 | 2002 | 261 | 0.050 |
Why?
|
| Intracellular Fluid | 1 | 2000 | 201 | 0.040 |
Why?
|
| Antigens, Surface | 2 | 2004 | 1606 | 0.040 |
Why?
|
| Interleukin-10 | 2 | 2017 | 1175 | 0.040 |
Why?
|
| Escherichia coli | 6 | 2019 | 4217 | 0.040 |
Why?
|
| Medically Underserved Area | 1 | 2022 | 254 | 0.040 |
Why?
|
| Hemolysin Proteins | 1 | 2000 | 113 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 26125 | 0.040 |
Why?
|
| I-kappa B Proteins | 1 | 2001 | 211 | 0.040 |
Why?
|
| HIV Infections | 2 | 2018 | 17351 | 0.040 |
Why?
|
| Basophil Degranulation Test | 1 | 2020 | 20 | 0.040 |
Why?
|
| Dermatophagoides farinae | 1 | 2019 | 19 | 0.040 |
Why?
|
| Interleukin-12 Subunit p35 | 1 | 2019 | 21 | 0.040 |
Why?
|
| Virulence | 3 | 2014 | 1303 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2014 | 12341 | 0.040 |
Why?
|
| Bipolar Disorder | 1 | 2017 | 5092 | 0.040 |
Why?
|
| alpha-Galactosidase | 1 | 2020 | 57 | 0.040 |
Why?
|
| Forkhead Transcription Factors | 1 | 2007 | 1616 | 0.040 |
Why?
|
| Adolescent | 7 | 2017 | 88319 | 0.040 |
Why?
|
| Aged | 14 | 2017 | 169289 | 0.040 |
Why?
|
| Cell Lineage | 3 | 2013 | 2555 | 0.040 |
Why?
|
| Lipoproteins | 2 | 2007 | 881 | 0.040 |
Why?
|
| Caspase 8 | 1 | 2020 | 190 | 0.040 |
Why?
|
| Pyrroles | 1 | 2006 | 1125 | 0.040 |
Why?
|
| Quality Indicators, Health Care | 1 | 2009 | 1792 | 0.040 |
Why?
|
| Antigens, Dermatophagoides | 1 | 2019 | 98 | 0.040 |
Why?
|
| Quality Improvement | 1 | 2015 | 3801 | 0.040 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2000 | 169 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2007 | 2665 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2014 | 3415 | 0.040 |
Why?
|
| Software | 1 | 2013 | 4434 | 0.040 |
Why?
|
| Genotype | 4 | 2017 | 12990 | 0.040 |
Why?
|
| Depressive Disorder, Major | 1 | 2017 | 4761 | 0.040 |
Why?
|
| CDP-Diacylglycerol-Inositol 3-Phosphatidyltransferase | 1 | 1999 | 3 | 0.040 |
Why?
|
| Furans | 1 | 2000 | 202 | 0.040 |
Why?
|
| Vibrio cholerae | 1 | 2005 | 793 | 0.040 |
Why?
|
| Pulmonary Eosinophilia | 1 | 2019 | 78 | 0.040 |
Why?
|
| United States | 6 | 2021 | 72334 | 0.040 |
Why?
|
| Caspase 1 | 1 | 2020 | 225 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 1991 | 4544 | 0.040 |
Why?
|
| Diet | 1 | 2017 | 8075 | 0.040 |
Why?
|
| Dimerization | 1 | 2000 | 891 | 0.040 |
Why?
|
| Cations, Divalent | 1 | 1999 | 168 | 0.040 |
Why?
|
| Multienzyme Complexes | 1 | 2002 | 666 | 0.040 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2014 | 3763 | 0.040 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2010 | 1640 | 0.040 |
Why?
|
| Sugar Phosphates | 1 | 1998 | 44 | 0.040 |
Why?
|
| Prodrugs | 1 | 2000 | 261 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2013 | 3778 | 0.040 |
Why?
|
| Hospitals, Teaching | 1 | 2023 | 1156 | 0.040 |
Why?
|
| Child | 3 | 2022 | 80153 | 0.040 |
Why?
|
| Schizophrenia | 1 | 2017 | 6937 | 0.040 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2007 | 1070 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 2 | 2006 | 3792 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2001 | 641 | 0.040 |
Why?
|
| Research Design | 1 | 2014 | 6180 | 0.040 |
Why?
|
| Peptides | 3 | 2006 | 4358 | 0.040 |
Why?
|
| Anti-Infective Agents | 1 | 2005 | 983 | 0.040 |
Why?
|
| Recombinant Proteins | 3 | 2003 | 6534 | 0.040 |
Why?
|
| Inositol | 1 | 1999 | 215 | 0.040 |
Why?
|
| Radioisotope Dilution Technique | 1 | 1997 | 71 | 0.040 |
Why?
|
| Cell Movement | 1 | 2010 | 5203 | 0.040 |
Why?
|
| Indoles | 1 | 2006 | 1833 | 0.040 |
Why?
|
| Disaster Planning | 1 | 2004 | 557 | 0.040 |
Why?
|
| Corynebacterium | 1 | 1997 | 48 | 0.040 |
Why?
|
| Pyruvates | 2 | 1995 | 84 | 0.040 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2019 | 755 | 0.040 |
Why?
|
| Receptors, Immunologic | 2 | 2019 | 1410 | 0.040 |
Why?
|
| Nuclear Transfer Techniques | 1 | 2017 | 61 | 0.040 |
Why?
|
| Cytosol | 1 | 2000 | 888 | 0.040 |
Why?
|
| Typhoid Fever | 1 | 2019 | 194 | 0.040 |
Why?
|
| Lipopeptides | 1 | 1997 | 71 | 0.040 |
Why?
|
| Trisaccharides | 2 | 1997 | 50 | 0.040 |
Why?
|
| Heat-Shock Proteins | 2 | 1992 | 795 | 0.040 |
Why?
|
| Pentoses | 1 | 1996 | 7 | 0.040 |
Why?
|
| Tritium | 1 | 1997 | 708 | 0.030 |
Why?
|
| Glycosylation | 2 | 2002 | 1098 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2004 | 10766 | 0.030 |
Why?
|
| Autoantibodies | 1 | 2005 | 2116 | 0.030 |
Why?
|
| Models, Structural | 1 | 1997 | 340 | 0.030 |
Why?
|
| Interleukin-12 | 1 | 1999 | 584 | 0.030 |
Why?
|
| Sepsis | 1 | 2011 | 2585 | 0.030 |
Why?
|
| Young Adult | 4 | 2017 | 59243 | 0.030 |
Why?
|
| Amino Acids | 2 | 2013 | 1718 | 0.030 |
Why?
|
| Bacteroides fragilis | 1 | 2018 | 252 | 0.030 |
Why?
|
| Uridine Diphosphate N-Acetylglucosamine | 1 | 1996 | 18 | 0.030 |
Why?
|
| Fibrosis | 1 | 2023 | 2049 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2006 | 2865 | 0.030 |
Why?
|
| Epitopes | 3 | 1993 | 2503 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 4575 | 0.030 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2017 | 152 | 0.030 |
Why?
|
| Models, Molecular | 3 | 2013 | 5439 | 0.030 |
Why?
|
| Mentors | 2 | 2015 | 661 | 0.030 |
Why?
|
| Sulfonamides | 1 | 2006 | 1978 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2001 | 1246 | 0.030 |
Why?
|
| Urinalysis | 1 | 2018 | 368 | 0.030 |
Why?
|
| Laboratories, Hospital | 1 | 2017 | 192 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2011 | 1541 | 0.030 |
Why?
|
| Lung | 3 | 2024 | 10000 | 0.030 |
Why?
|
| Isoenzymes | 1 | 2000 | 1687 | 0.030 |
Why?
|
| Early Growth Response Protein 2 | 1 | 2015 | 25 | 0.030 |
Why?
|
| Alkylation | 1 | 1995 | 84 | 0.030 |
Why?
|
| NF-kappa B | 2 | 2001 | 2490 | 0.030 |
Why?
|
| Protein Conformation | 3 | 2013 | 3968 | 0.030 |
Why?
|
| Deuterium | 1 | 1995 | 106 | 0.030 |
Why?
|
| Gene Regulatory Networks | 2 | 2014 | 1745 | 0.030 |
Why?
|
| Galactose | 1 | 1996 | 297 | 0.030 |
Why?
|
| Inflammasomes | 1 | 2020 | 526 | 0.030 |
Why?
|
| Flavonoids | 1 | 1998 | 445 | 0.030 |
Why?
|
| Patients' Rooms | 1 | 1995 | 62 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2006 | 3673 | 0.030 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2014 | 221 | 0.030 |
Why?
|
| T-Box Domain Proteins | 1 | 2017 | 469 | 0.030 |
Why?
|
| DNA Fingerprinting | 2 | 2009 | 114 | 0.030 |
Why?
|
| Internship and Residency | 1 | 2015 | 5880 | 0.030 |
Why?
|
| Monocytes | 2 | 2005 | 2570 | 0.030 |
Why?
|
| Ligands | 2 | 2019 | 3272 | 0.030 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2014 | 150 | 0.030 |
Why?
|
| Phylogeny | 2 | 2019 | 2811 | 0.030 |
Why?
|
| Access to Information | 1 | 2017 | 316 | 0.030 |
Why?
|
| Antigen-Presenting Cells | 2 | 1995 | 964 | 0.030 |
Why?
|
| Cell Growth Processes | 1 | 2014 | 384 | 0.030 |
Why?
|
| Cohort Studies | 4 | 2023 | 41487 | 0.030 |
Why?
|
| Mycobacterium chelonae | 1 | 1993 | 12 | 0.030 |
Why?
|
| Molecular Weight | 2 | 1997 | 2186 | 0.030 |
Why?
|
| Isomerism | 1 | 1993 | 197 | 0.030 |
Why?
|
| Hybridomas | 2 | 1992 | 442 | 0.030 |
Why?
|
| Perforin | 1 | 2014 | 167 | 0.030 |
Why?
|
| Glycosides | 1 | 1993 | 100 | 0.030 |
Why?
|
| Clarithromycin | 1 | 1993 | 86 | 0.030 |
Why?
|
| Antibodies, Bacterial | 3 | 2006 | 1469 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2002 | 3734 | 0.030 |
Why?
|
| Receptors, Virus | 1 | 1996 | 640 | 0.030 |
Why?
|
| Structure-Activity Relationship | 3 | 2007 | 3076 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 13639 | 0.030 |
Why?
|
| Pyruvic Acid | 1 | 1994 | 204 | 0.030 |
Why?
|
| RNA | 1 | 2023 | 2726 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 1999 | 3597 | 0.030 |
Why?
|
| Transplantation Immunology | 1 | 1995 | 532 | 0.030 |
Why?
|
| Isoelectric Point | 1 | 2012 | 76 | 0.030 |
Why?
|
| Statistics as Topic | 1 | 1999 | 2358 | 0.030 |
Why?
|
| Hydrolysis | 1 | 1993 | 664 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2010 | 7390 | 0.030 |
Why?
|
| Algorithms | 1 | 2013 | 14031 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2017 | 1967 | 0.030 |
Why?
|
| Methylation | 1 | 1995 | 1084 | 0.030 |
Why?
|
| Feces | 1 | 2019 | 1497 | 0.030 |
Why?
|
| Succinates | 1 | 2012 | 81 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 2001 | 2135 | 0.020 |
Why?
|
| Histocompatibility Antigens | 1 | 2013 | 464 | 0.020 |
Why?
|
| Aged, 80 and over | 4 | 2011 | 58976 | 0.020 |
Why?
|
| Sequence Alignment | 3 | 2002 | 2180 | 0.020 |
Why?
|
| Risk Factors | 6 | 2011 | 74206 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2013 | 347 | 0.020 |
Why?
|
| Genome, Bacterial | 2 | 2006 | 783 | 0.020 |
Why?
|
| Immune Sera | 1 | 1991 | 606 | 0.020 |
Why?
|
| Interleukin-17 | 1 | 2017 | 912 | 0.020 |
Why?
|
| Protein Binding | 2 | 2014 | 9351 | 0.020 |
Why?
|
| Immunization | 1 | 1995 | 1228 | 0.020 |
Why?
|
| Purchasing, Hospital | 1 | 2010 | 14 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2014 | 1341 | 0.020 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2013 | 452 | 0.020 |
Why?
|
| Genes, T-Cell Receptor alpha | 1 | 2009 | 19 | 0.020 |
Why?
|
| Drosophila Proteins | 1 | 1999 | 1699 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 1999 | 2822 | 0.020 |
Why?
|
| Genes, T-Cell Receptor beta | 1 | 2009 | 71 | 0.020 |
Why?
|
| Immunity, Cellular | 2 | 1995 | 1560 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2012 | 749 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2006 | 5671 | 0.020 |
Why?
|
| Philippines | 1 | 2009 | 90 | 0.020 |
Why?
|
| Organizational Case Studies | 1 | 2010 | 301 | 0.020 |
Why?
|
| Repressor Proteins | 2 | 2013 | 2986 | 0.020 |
Why?
|
| Autoradiography | 2 | 2002 | 728 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2011 | 23995 | 0.020 |
Why?
|
| Forms and Records Control | 1 | 2009 | 158 | 0.020 |
Why?
|
| Health Personnel | 1 | 2023 | 3335 | 0.020 |
Why?
|
| Multifactorial Inheritance | 1 | 2017 | 1387 | 0.020 |
Why?
|
| Phagocytosis | 1 | 2014 | 1528 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2001 | 517 | 0.020 |
Why?
|
| Minisatellite Repeats | 1 | 2009 | 163 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2010 | 473 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 1999 | 3702 | 0.020 |
Why?
|
| Phosphates | 1 | 2012 | 770 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2014 | 3615 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2018 | 20098 | 0.020 |
Why?
|
| Curriculum | 2 | 2015 | 3743 | 0.020 |
Why?
|
| Physician's Role | 1 | 2015 | 917 | 0.020 |
Why?
|
| Receptors, IgG | 1 | 1991 | 559 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2001 | 4936 | 0.020 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1999 | 2688 | 0.020 |
Why?
|
| DNA Primers | 2 | 2002 | 2819 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2014 | 1893 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2023 | 12795 | 0.020 |
Why?
|
| Adaptive Immunity | 1 | 2012 | 726 | 0.020 |
Why?
|
| Patient Admission | 1 | 1995 | 1367 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2012 | 1699 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2019 | 3396 | 0.020 |
Why?
|
| Cytoplasm | 1 | 1992 | 1510 | 0.020 |
Why?
|
| Molecular Epidemiology | 1 | 2009 | 469 | 0.020 |
Why?
|
| Tuberculin | 1 | 2006 | 64 | 0.020 |
Why?
|
| Repetitive Sequences, Amino Acid | 1 | 2006 | 92 | 0.020 |
Why?
|
| Cytotoxins | 1 | 2007 | 153 | 0.020 |
Why?
|
| Cell Fractionation | 1 | 2006 | 251 | 0.020 |
Why?
|
| Genome-Wide Association Study | 2 | 2017 | 12690 | 0.020 |
Why?
|
| Chimera | 1 | 2007 | 453 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2014 | 4615 | 0.020 |
Why?
|
| Phenotype | 3 | 2014 | 16591 | 0.020 |
Why?
|
| Antigens, Neoplasm | 1 | 2014 | 1993 | 0.020 |
Why?
|
| Mycobacterium marinum | 1 | 2005 | 29 | 0.020 |
Why?
|
| Healthcare Disparities | 1 | 2021 | 3358 | 0.020 |
Why?
|
| Inpatients | 1 | 2017 | 2548 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2010 | 1827 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2018 | 15266 | 0.020 |
Why?
|
| Base Sequence | 3 | 2002 | 12441 | 0.020 |
Why?
|
| Open Reading Frames | 2 | 2000 | 815 | 0.020 |
Why?
|
| Receptors, Interleukin-2 | 2 | 2003 | 562 | 0.020 |
Why?
|
| Rabbits | 1 | 1991 | 4772 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2010 | 2626 | 0.010 |
Why?
|
| Case-Control Studies | 2 | 2017 | 22176 | 0.010 |
Why?
|
| Comorbidity | 1 | 1999 | 10508 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 2007 | 1749 | 0.010 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2007 | 509 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2017 | 5492 | 0.010 |
Why?
|
| Thiophenes | 2 | 2000 | 569 | 0.010 |
Why?
|
| Medical Records | 1 | 2009 | 1408 | 0.010 |
Why?
|
| Receptors, Antigen | 1 | 2004 | 51 | 0.010 |
Why?
|
| Serologic Tests | 2 | 2000 | 381 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2017 | 17904 | 0.010 |
Why?
|
| Apoptosis | 1 | 2020 | 9486 | 0.010 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2005 | 219 | 0.010 |
Why?
|
| Glucose | 1 | 1995 | 4346 | 0.010 |
Why?
|
| Homeostasis | 1 | 2014 | 3323 | 0.010 |
Why?
|
| Spleen | 1 | 2009 | 2295 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2013 | 2856 | 0.010 |
Why?
|
| Carbon Isotopes | 1 | 2004 | 458 | 0.010 |
Why?
|
| Liver | 1 | 1999 | 7529 | 0.010 |
Why?
|
| Esters | 1 | 2004 | 211 | 0.010 |
Why?
|
| Lymphocyte Count | 1 | 2005 | 778 | 0.010 |
Why?
|
| Conflict of Interest | 1 | 2007 | 554 | 0.010 |
Why?
|
| Health Care Costs | 1 | 2016 | 3242 | 0.010 |
Why?
|
| Serine | 2 | 1997 | 830 | 0.010 |
Why?
|
| Rats | 1 | 1999 | 23742 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2014 | 15936 | 0.010 |
Why?
|
| Diagnostic Errors | 1 | 2009 | 1265 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 2005 | 1163 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2009 | 1667 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2019 | 7856 | 0.010 |
Why?
|
| Acyl-Carrier Protein S-Malonyltransferase | 1 | 2001 | 2 | 0.010 |
Why?
|
| Arginine | 1 | 2005 | 934 | 0.010 |
Why?
|
| Time Factors | 1 | 2003 | 39967 | 0.010 |
Why?
|
| Emergency Service, Hospital | 1 | 2021 | 7879 | 0.010 |
Why?
|
| MAP Kinase Kinase 7 | 1 | 2001 | 14 | 0.010 |
Why?
|
| Prevalence | 1 | 1998 | 15732 | 0.010 |
Why?
|
| Interprofessional Relations | 1 | 2007 | 990 | 0.010 |
Why?
|
| Amoxicillin | 1 | 2002 | 180 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2011 | 26198 | 0.010 |
Why?
|
| Urban Population | 1 | 2009 | 2036 | 0.010 |
Why?
|
| Length of Stay | 1 | 1995 | 6425 | 0.010 |
Why?
|
| Drug Industry | 1 | 2007 | 788 | 0.010 |
Why?
|
| Epidermis | 1 | 2004 | 528 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2005 | 1738 | 0.010 |
Why?
|
| Gene Expression | 1 | 2014 | 7581 | 0.010 |
Why?
|
| DNA-Binding Proteins | 2 | 2013 | 9606 | 0.010 |
Why?
|
| Lysine | 1 | 2005 | 993 | 0.010 |
Why?
|
| Syndrome | 1 | 2007 | 3267 | 0.010 |
Why?
|
| Multiprotein Complexes | 1 | 2007 | 1118 | 0.010 |
Why?
|
| Asthma | 1 | 2019 | 6234 | 0.010 |
Why?
|
| Enzyme Induction | 1 | 2001 | 452 | 0.010 |
Why?
|
| Biotransformation | 1 | 2000 | 166 | 0.010 |
Why?
|
| Patient Readmission | 1 | 1995 | 3270 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2016 | 64680 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2003 | 15631 | 0.010 |
Why?
|
| Genetic Complementation Test | 1 | 2001 | 554 | 0.010 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2006 | 2571 | 0.010 |
Why?
|
| Hexosamines | 1 | 1999 | 40 | 0.010 |
Why?
|
| Lipids | 2 | 2005 | 3341 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 2007 | 2416 | 0.010 |
Why?
|
| Academic Medical Centers | 1 | 2010 | 2759 | 0.010 |
Why?
|
| Sex Factors | 1 | 2013 | 10552 | 0.010 |
Why?
|
| Genomic Library | 1 | 1999 | 189 | 0.010 |
Why?
|
| Genome, Human | 1 | 2012 | 4425 | 0.010 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2001 | 332 | 0.010 |
Why?
|
| Penicillins | 1 | 2002 | 402 | 0.010 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2001 | 441 | 0.010 |
Why?
|
| Faculty, Medical | 1 | 2007 | 1203 | 0.010 |
Why?
|
| MicroRNAs | 1 | 2015 | 3816 | 0.010 |
Why?
|
| Rural Population | 1 | 2009 | 2285 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 2010 | 4471 | 0.010 |
Why?
|
| Oxidoreductases | 1 | 2000 | 413 | 0.010 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2001 | 687 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2001 | 1693 | 0.010 |
Why?
|
| Cord Factors | 1 | 1997 | 6 | 0.010 |
Why?
|
| Mutagenesis, Insertional | 1 | 2000 | 656 | 0.010 |
Why?
|
| Esterification | 1 | 1997 | 39 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 1990 | 5112 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2007 | 3208 | 0.010 |
Why?
|
| Base Composition | 1 | 1997 | 290 | 0.010 |
Why?
|
| Biopsy | 1 | 2009 | 6766 | 0.010 |
Why?
|
| Indicators and Reagents | 1 | 1998 | 462 | 0.010 |
Why?
|
| Palmitates | 1 | 1997 | 70 | 0.010 |
Why?
|
| Azides | 1 | 1997 | 118 | 0.010 |
Why?
|
| Disaccharides | 1 | 1997 | 170 | 0.010 |
Why?
|
| Fetal Blood | 1 | 2004 | 1347 | 0.010 |
Why?
|
| Glycoside Hydrolases | 1 | 1997 | 135 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2000 | 1646 | 0.010 |
Why?
|
| Age Factors | 1 | 2013 | 18395 | 0.010 |
Why?
|
| Palmitic Acid | 1 | 1997 | 149 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2004 | 2645 | 0.010 |
Why?
|
| Isotope Labeling | 1 | 1998 | 392 | 0.010 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1997 | 767 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1997 | 1058 | 0.010 |
Why?
|
| Cell Division | 1 | 2004 | 4465 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1996 | 851 | 0.010 |
Why?
|
| Plasmids | 1 | 2001 | 2269 | 0.010 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1997 | 1302 | 0.010 |
Why?
|
| Toll-Like Receptors | 1 | 1999 | 589 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2006 | 4740 | 0.010 |
Why?
|
| Biopolymers | 1 | 1996 | 184 | 0.010 |
Why?
|
| Crohn Disease | 1 | 1988 | 2279 | 0.010 |
Why?
|
| Skin | 1 | 2009 | 4484 | 0.010 |
Why?
|
| Culture Media | 1 | 1997 | 897 | 0.010 |
Why?
|
| Polyisoprenyl Phosphate Monosaccharides | 1 | 1994 | 3 | 0.010 |
Why?
|
| Selection, Genetic | 1 | 1999 | 868 | 0.010 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 1996 | 506 | 0.010 |
Why?
|
| Quality Assurance, Health Care | 1 | 2005 | 2169 | 0.010 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2007 | 2223 | 0.010 |
Why?
|
| Temperature | 1 | 2001 | 2226 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2014 | 18252 | 0.010 |
Why?
|
| Physician-Patient Relations | 1 | 2007 | 3249 | 0.010 |
Why?
|
| Escherichia coli Proteins | 1 | 2001 | 1067 | 0.010 |
Why?
|
| Culture Media, Conditioned | 1 | 1995 | 522 | 0.010 |
Why?
|
| DNA Transposable Elements | 1 | 1997 | 755 | 0.010 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 1997 | 1039 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2013 | 12128 | 0.010 |
Why?
|
| India | 1 | 2000 | 2348 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1997 | 2496 | 0.010 |
Why?
|
| Telemedicine | 1 | 2010 | 3051 | 0.010 |
Why?
|
| BCG Vaccine | 1 | 1995 | 369 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1999 | 6132 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2007 | 8002 | 0.010 |
Why?
|
| Transfection | 1 | 1999 | 5774 | 0.010 |
Why?
|
| Genetic Markers | 1 | 1997 | 2601 | 0.010 |
Why?
|
| Histoplasmosis | 1 | 1990 | 63 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2007 | 16981 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2004 | 11076 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2003 | 12059 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1990 | 1624 | 0.000 |
Why?
|
| Lipid A | 1 | 1988 | 70 | 0.000 |
Why?
|
| False Positive Reactions | 1 | 1990 | 957 | 0.000 |
Why?
|
| Immunocompromised Host | 1 | 1993 | 856 | 0.000 |
Why?
|
| Glioma | 1 | 2003 | 3455 | 0.000 |
Why?
|
| Neoplasms | 1 | 2016 | 22170 | 0.000 |
Why?
|
| Immunoglobulins | 1 | 1988 | 853 | 0.000 |
Why?
|
| Mice, Inbred C3H | 1 | 1985 | 915 | 0.000 |
Why?
|
| Binding, Competitive | 1 | 1985 | 1141 | 0.000 |
Why?
|
| Interleukin-1 | 1 | 1985 | 1248 | 0.000 |
Why?
|
| Mutation | 1 | 2001 | 30052 | 0.000 |
Why?
|